PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research team could redefine biomedical research

Professor Leslie Wolf is a part of a research team that has been provided $1.9 million to conduct research designed to increase participation in biomedical studies by involving participants in the research design process

Research team could redefine biomedical research
2025-02-04
(Press-News.org) Professor Leslie Wolf, a Distinguished University Professor and Ben F. Johnson Jr. Chair in Law at Georgia State University College of Law, is a part of a research team that has been provided $1.9 million to conduct research designed to increase participation in biomedical studies by involving participants in the research design process. The award has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract.

Wolf, along with colleagues at the Medical College of Georgia at Augusta University , the University of Wisconsin-Madison, and the HUB Augusta Collaborative Inc., received the award from the Patient-Centered Outcomes Research Institute (PCORI), an independent, non-profit organization, authorized by Congress in 2010, that funds patient-centered research in the U.S.

The study funded by the award, entitled Co-Creating Novel, Feasible and Inclusive Research Methods (CONFIRM), aims to discover whether people are more likely to take part in a research study if they play a role in how the study is designed and what activities are involved. This collaborative approach seeks to empower participants as co-researchers to ensure that the study methods are acceptable and relevant to the needs of participants and their community.

In an Augusta Chronicle article, PCORI Executive Director Nakela L. Cook, MD, touted the anticipated benefits of such an approach. “This study was selected for PCORI funding for its potential to strengthen patient-centered... research by providing evidence about specific engagement methods and measures that promote representative engagement of patients and other stakeholders in research,” she said.

The researchers aim to improve a longstanding challenge in research: ensuring that study designs are both inclusive and representative of the populations they intend to serve.

Research studies of all kinds are often limited to the people who are willing and able to participate in them, which can lead to results that do not reflect the full diversity of the population. Increasing participation in underrepresented communities can give researchers more accurate insights and lead to more meaningful results.

“All of us who worked on this grant are deeply committed to conducting research that is responsive to community needs and in engaging community members in that process,” said Wolf.

If successful, this study would indicate that it is beneficial to flip the usual order of research, where tasks and activities are decided first and participants are recruited later. A positive outcome could also have implications for research methods in a variety of fields.

“If we are correct, our findings would provide support for other researchers to adopt this model, and ultimately increase the relevance, trustworthiness and usefulness of research findings,” said Wolf.

Wolf will be working with the academic research team and community co-researchers on all aspects of this study, sharing her expertise on the law and ethics of research involving humans to inform their choices, as well as helping to develop processes that facilitate decision-making within the group.

This project draws on Wolf’s broad background of expertise identifying how researchers can best respect the rights and well-being of participants while conducting essential research. Wolf is also a leading expert in methods to conduct ethical, responsive research in non-traditional settings and in non-traditional ways.

“My recent research has focused on how we can make research more inclusive and, thus, better realize the core research ethics principle of justice. This project is consistent with that research, extending it in exciting ways by building on my collaborations with colleagues at Augusta University to answer a question that could transform biomedical research.”

Anne Tucker, associate dean of Research & Faculty Development at Georgia State Law, praised Wolf for her accomplishment. “This study demonstrates why Professor Wolf is a nationally recognized expert in research ethics,” she said. “Her work seeks to increase participation in research studies, a need that is particularly acute for women and racial minorities to combat health disparities.”

Professor Wolf currently serves as the director of the Center for Law, Health & Society at Georgia State Law and teaches Torts, seminars in Bioethics, Human Subjects Research, and related health law courses.

END

[Attachments] See images for this press release:
Research team could redefine biomedical research

ELSE PRESS RELEASES FROM THIS DATE:

Bridging a gap in carbon removal strategies

2025-02-04
Biochar: bridging a gap in carbon removal strategies   As the world works to meet net-zero carbon goals, a new study offers a critical reminder: precision matters. The researchers suggest refining how we assess a natural carbon storage strategy to ensure the technology lives up to its potential as a climate change solution.   Biochar, a charcoal-like material derived from plant biomass, has long been hailed as a promising tool for carbon dioxide removal. However, a new study by Stanford researchers highlights a critical issue: current methods for assessing biochar's carbon storage potential may significantly undervalue its true ...

Outside-in signaling shows a route into cancer cells

2025-02-04
A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism that could be exploited for delivering other drugs.  Many malignant cancers overexpress a protein called P-cadherin, which is embedded in the cell membrane. Because cancer cells have a lot of P-cadherin sticking out of their surface, the protein has been targeted for drug development.  Monoclonal antibodies against P-cadherin can carry a drug payload to the cancer cells. It has not been clear, though, exactly how the antibodies attach to P-cadherin ...

NFL wives bring signature safe swim event to New Orleans

2025-02-04
NEW ORLEANS, Feb. 4, 2025 — The American Heart Association, a global force changing the future of health, is promoting water safety, a multi-market priority initiative for the Off the Field National Football League Wives Association. The American Heart Association provided Hands-Only cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) education as part of the safe swim event held at Tulane University’s Reily Center on Tuesday, Feb. 4. The event welcomed nearly ...

Pickleball program boosts health and wellness for cancer survivors, Moffitt study finds

2025-02-04
TAMPA, Fla. (Feb. 4, 2025) — A new community-based pickleball program called Project Rally is helping cancer survivors improve their physical and social well-being, according to a recent pilot study led by researchers at Moffitt Cancer Center. The program, which is offered in partnership with the YMCA of the Suncoast, has shown strong results in terms of participation, enjoyment, and physical improvements. Staying active is a key part of cancer survivorship care and research. Physical activity can help reduce the negative effects of cancer and its treatments, while also empowering survivors to live fulfilling lives. It offers many ...

International Alzheimer’s prevention trial in young adults begins

International Alzheimer’s prevention trial in young adults begins
2025-02-04
The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high risk of the disease have been enrolled. The trial, led by Washington University School of Medicine in St. Louis, aims to determine whether stopping the early molecular changes that lead to symptomatic Alzheimer’s disease can prevent the disease from ever taking hold. The study is enrolling people as young as 18 who have few or no detectable Alzheimer’s-related molecular changes in their brains, up to 25 years before the expected onset ...

Why your headphone battery doesn't last

Why your headphone battery doesnt last
2025-02-04
Ever notice that batteries in electronics don't last as long as they did when they were brand new?  An international research team led by The University of Texas at Austin took on this well-known battery challenge, called degradation, with a twist. They're focusing their work on real-world technology that many of us use daily: wireless earbuds. They deployed x-ray, infrared, and other imaging technologies to understand the complexities of all the technology packed in these tiny devices and learn why their battery lives erode over time. "This started with my personal headphones; I only wear the right one, and I found ...

Study probes how to predict complications from preeclampsia

Study probes how to predict complications from preeclampsia
2025-02-04
The existing prediction models for severe complications of preeclampsia are most accurate only in the two days after hospital admission, with deteriorating performance over time, according to a new study published February 4th in the open-access journal PLOS Medicine by Henk Groen of University of Groningen, the Netherlands, and colleagues. Preeclampsia is a potentially life-threatening condition that can occur during pregnancy; of women diagnosed with preeclampsia, 5-20% will develop severe complications. Two existing PIERS (Pre-eclampsia Integrated ...

CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs
2025-02-04
A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with international partners, has designed a strategy for preventing the cardiotoxic effects of anthracyclines, a widely used class of anticancer drugs. Cardiotoxicity is a frequent adverse secondary effect of cancer therapy with these drugs. The study, published in JACC: CardioOncology, demonstrates that treatment with the SGLT2 inhibitor empagliflozin can mitigate the cardiac injury associated with anthracycline therapy. Anthracyclines are first-line medications in the treatment of cancer, but in 5% of patients their use is associated ...

NYU’s Yann LeCun a winner of the 2025 Queen Elizabeth Prize for Engineering

2025-02-04
New York University’s Yann LeCun has been selected as a winner of the 2025 Queen Elizabeth Prize for Engineering—one of seven recognized for contributions to the advancement of Modern Machine Learning, which has fueled advances in artificial intelligence.  “This year, we celebrate the remarkable achievements that these seven engineers have contributed to Modern Machine Learning, a field that has revolutionized artificial intelligence by uniting algorithms, hardware, and data,” said Lord Vallance, chair of the Queen Elizabeth Prize for Engineering Foundation. “The impact of this innovation is felt across industries, economies, and the planet, ...

New study assesses impact of agricultural research investments on biodiversity, land use

New study assesses impact of agricultural research investments on biodiversity, land use
2025-02-04
New study assesses impact of agricultural research investments on biodiversity and land use Data analysis spans 1960s Green Revolution to 2015 WEST LAFAYETTE, Ind. — New, groundbreaking research shows how, at a local scale, agricultural research and development led to improved crop varieties that resulted in global benefits to the environment and food system sustainability. The Purdue University study appears in the latest issue of Proceedings of the National Academy of Sciences. “At the global level, we see a reduction in cropland use from these technology ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] Research team could redefine biomedical research
Professor Leslie Wolf is a part of a research team that has been provided $1.9 million to conduct research designed to increase participation in biomedical studies by involving participants in the research design process